STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRAPRNewsWire • 04/10/24
KINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRABusiness Wire • 04/05/24
Shareholder Alert: Ademi LLP investigates whether Kintara Therapeutics, Inc. has obtained a Fair Price in its transaction with TuHURAPRNewsWire • 04/03/24
KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to ShareholdersBusiness Wire • 04/03/24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger AgreementPRNewsWire • 04/03/24
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on PembrolizumabPRNewsWire • 03/27/24
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 02/14/24
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast CancerPRNewsWire • 02/12/24
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January - Corcept Therapeutics (NASDAQ:CORT), Kintara Therapeutics (NASDAQ:KTRA)Benzinga • 01/02/24
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)Benzinga • 12/18/23
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing RequirementPRNewsWire • 12/05/23
Top 5 Health Care Stocks That Could Blast Off In December - DBV Technologies (NASDAQ:DBVT), Cigna Group (NYSE:CI)Benzinga • 12/01/23
Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 11/13/23
Kintara Therapeutics to Present at the 8th Annual Dawson James Small Cap Growth ConferencePRNewsWire • 10/11/23
Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual MeetingPRNewsWire • 09/25/23
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate UpdatePRNewsWire • 09/18/23
Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual MeetingPRNewsWire • 09/05/23
Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023PRNewsWire • 08/17/23